secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0001213900-25-044913
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma closes $2M public offering of common stock and warrants
-------------------------------------------------------------------

- Offered 3,333,338 shares (or pre-funded warrants) plus Series A-1 and A-2 warrants for up to 3,333,338 shares each.
- Combined price $0.60/unit; gross proceeds ~$2M, net ~$1.56M after fees and expenses.
- Series A-1 warrants exercise price $0.60, expire 5 years; Series A-2 warrants $0.60, expire 18 months from issuance.
- H.C. Wainwright exclusive placement agent; received 7.5% cash fee, 1% management fee, and 250,000 warrants at $0.75.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390025044913/0001213900-25-044913-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390025044913/ea0242442-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-044913

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer